Addressing Neuronal Stress and Neuroinflammation in Brain Radiation Therapy
Overview
Radiation therapy for brain tumors induces widespread DNA methylation changes in non-cancerous brain tissue, triggering neuroinflammation and neuronal stress. Millner et al. demonstrate that these epigenetic alterations disrupt cellular communication between neurons, glia, and immune cells, contributing to adverse effects such as cognitive decline and vascular complications.
Background
Radiation therapy (RT) is a cornerstone treatment for primary and metastatic brain tumors but is limited by the sensitivity of brain structures and the risk of long-term adverse effects. Despite advances in RT techniques improving dose conformity, patients often experience cognitive deterioration, vascular damage, and radiation necrosis. Pseudoprogression, an inflammatory and vascular reaction mimicking tumor growth, complicates clinical management. The molecular mechanisms underlying RT-induced brain injury, particularly in healthy tissue, remain incompletely understood but involve DNA damage and epigenetic modifications such as DNA methylation.
Data Highlights
Millner et al. performed multi-omic analyses on irradiated peri-lesional human brain tissue and cerebral organoid models, revealing:
Widespread loss of DNA methylation at regulatory regions of genes linked to neuroinflammation and brain injury.
Neuronal markers of senescence and inflammation, with altered neuropeptide gene expression (TAC1, PENK).
Disrupted cellular communication involving trophic and inflammatory signaling molecules (BDNF, PDGF, APP, CD44).
Co-localization of DNA methyltransferases with DNA damage sites and altered expression of DNA methylation enzymes post-irradiation.
Key Findings
Brain irradiation induces significant epigenetic changes, primarily loss of DNA methylation in regulatory regions controlling neuroinflammatory genes.
Neurons in irradiated tissue exhibit senescence and inflammatory phenotypes, potentially driven by dysregulated neuropeptides such as tachykinins and endogenous opioids.
Neuronal niches engage in altered trophic and inflammatory interactions with glial and immune cells, contributing to neuroinflammation.
DNA methylation machinery enzymes (DNMTs and TETs) are involved in the response to DNA damage and epigenetic remodeling after RT.
Cerebral organoid models recapitulate key epigenetic and transcriptional changes observed in patient tissue, validating their use for mechanistic studies.
Clinical Implications
Understanding the epigenetic and neuroinflammatory pathways activated by brain RT highlights potential targets to protect normal brain tissue. Therapeutic strategies aimed at modulating DNA methylation or neuropeptide signaling may mitigate cognitive decline and vascular complications without compromising tumor control. Improved biomarkers distinguishing pseudoprogression from true tumor progression could reduce unnecessary interventions.
Conclusion
Millner et al. provide compelling evidence that RT-induced DNA methylation disruption underpins neuroinflammation and neuronal stress in the brain, offering new insights into the molecular basis of RT-associated adverse effects. These findings pave the way for developing protective interventions to improve patient outcomes.
